Document Sciences and Xerox Agree on Global Co-Marketing Agreement.

Business Editors, High-Tech Writers

CARLSBAD, Calif.--(BUSINESS WIRE)--May 19, 2000

Document Sciences (Nasdaq:DOCX), a global leader in Document Automation solutions, and Xerox Corporation (NYSE:XRX) today announced that Xerox' healthcare and financial services business will use Document Sciences' suite of Autograph products in its portfolio of solutions.

"By integrating our suite of products into globally marketed Xerox solutions, the Financial Services and Healthcare ISU will be able to offer its customers the very best in document automation technology, along with a comprehensive suite of professional services, including facilities maintenance outsourcing," said Dan Fregeau, Document Sciences' vice president of worldwide sales and business development. "This further strengthens our unique relationship with Xerox."

The solutions will be marketed and sold by Xerox in the United States, Canada, and Europe. The new global alliance agreement includes consideration for VAR program fees, training and certification, and the sharing of relevant domain expertise.

The Autograph suite, including Visual CompuSet Pro(TM), DLS Web Express(TM), and the company's flagship Color CompuSet(R) composition engine, are used to transform data and content into high-quality variable document streams for high-volume or on-demand print and web distribution. With the new agreement, joint document automation solutions will be made available for Automated Marketing Fulfillment, High-Value Statements, Regulated Policies and Contracts, and Enterprise Correspondence. These applications each represent a major component of the Customer Relationship Management (CRM) Cycle which corporations worldwide depend on for effectively communicating with business customers and consumers.

"This technology supports our commitment to deliver integrated solutions which truly meet customers' document management needs," said Philip S. Pilibosian, senior vice president and general manager, Xerox Worldwide Financial Services and Healthcare Industry Business Operations. "This is particularly important in industries such as health insurance where mass customization of documents, produced and delivered on demand, is so critical to the CRM Cycle."

About Document Sciences Corporation

Document Sciences Corporation is the world's leading provider of Enterprise Document Automation Software. The company provides a family of document automation products and services that enable an enterprise to better communicate with their customers through high-quality personalized and customized documents that can be printed, viewed on demand, or distributed electronically in high volume. The Company licenses its products to over 680 customers worldwide in insurance, banking and financial services, managed care, telecommunications, utilities, and commercial print service bureaus. Based in Carlsbad, California, with regional locations across the U.S. and a European subsidiary in Paris, France, the Company also markets its products in Australia, New Zealand, Brazil, Argentina and Chile. For more information, visit the Document Sciences web site at www.docscience.com

About Xerox

Xerox Corporation is a $19 billion enterprise serving the worldwide document processing market. It develops, manufactures, markets, services and finances a full range of products and services that make businesses more productive. For more information, visit www.xerox.com

This press release contains forward-looking statements. In particular, words such as "may," "will," "should," "could," "expects," "plans," "anticipates," "believes," "estimates," "predicts," "potential," or "continue" or the negative of such terms or other expressions which such forward-looking statements are by their nature predictions based upon current plans, expectations, estimates, and assumptions. These statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activities, performance, or achievements expressed or by such forward-looking statements. Other risks and uncertainties associated with the business of the Company may be reviewed in the Company's public filings, including the Company's Annual Report on Form 10-K for its fiscal year ended December 31, 1999 and its Quarterly Reports on Form 10-Q on file with the Securities and Exchange Commission.